Login Stem Cell (SCIA)
Description
SCI is a platform focused on international research, development, and implementation of stem cell therapy. It is also expanding its network with professionals, labs, clinics, hospitals, and nonprofit organizations. SCI ultimate goal at SCI is to connect people who need treatment with the right dedicated solutions and professionals for their unique needs. Users will be able to connect with a Stem Cell Specialist instantly through our Stem Cell Innovations application (SCI Application), and in the same connection be able to decide when and how much confidential information to share with professionals.
The SCIA token is an Etherum-based (ERC-20) cryptocurrency. It is the exclusive means for the users to purchase an access available through SCIA Application.
| Full Name | Stem Cell (SCIA) |
|---|---|
| Start Date | N/A |
| Algorithm | ETH Token |
| Proof Type | N/A |
| Website | scia.io/# |
| @stemcellapp | |
| N/A | |
| N/A | |
| Block Number | N/A |
| Block Time | N/A |
| Block Reward | N/A |
| Previous Total Coins Mined | N/A |
| Net Hashes Per Second | N/A |
ICO Details
SCI is a platform focused on international research, development, and implementation of stem cell therapy. It is also expanding its network with professionals, labs, clinics, hospitals, and nonprofit organizations. SCI ultimate goal at SCI is to connect people who need treatment with the right dedicated solutions and professionals for their unique needs. Users will be able to connect with a Stem Cell Specialist instantly through our Stem Cell Innovations application (SCI Application), and in the same connection be able to decide when and how much confidential information to share with professionals.
The SCIA token is an Etherum-based (ERC-20) cryptocurrency. It is the exclusive means for the users to purchase an access available through SCIA Application.
Team:
- Moe Galal: Chief Executive Officer / Founder.
- Ben Barel: Chief Operations Officer / Co-Founder.
- Ali Alrashidi: Chief Technology Officer / Co-Founder.
- Matt Galal: Chief of Staff / Co-Founder.
Stem Cell ICO will begin on November 21, 2018. The ICO token supply represents 30% of the total token supply, so there is a total of 240,000,000 SCIA tokens available, for 0.15 USD each. The ICO funding target is 3,000,000 USD, the funding cap is 36,000,000 USD and is expected to end on January 17, 2019 or when the funding cap is reached. The unsold/remaining tokens will be burned.
Token Reserve Split (70%):
- 25% IT and development R&D;
- 19% Team and Advisors;
- 15% International expansion and partnership of Stem Cell labs;
- 6% Lobbying Stem Cell US FDA;
- 5% Legal.
Stem Cell ICO features up to 60% bonus on the Pre-sale and up to 30% on the Main Sale.
| ICO Status | Upcoming |
|---|---|
| Token Supply | 800000000 |
| Start Date | 2018-11-21 |
| End Date | 2019-01-17 |
| Fund Raised (BTC) | N/A |
| Fund Raised (USD) | N/A |
| Start Price (USD) | 0.15 |
| Security Audit Company | N/A |
| ICO Legal Form | Corporation |
| ICO Jurisdiction | Gibraltar |
| Legal Advisers | N/A |
| Blog | https://medium.com/@stemcellapp |
| White Paper | scia.io/white_paper_v1.1.pdf |
